Rhenman & Partners Asset Management AB
Position in A — Agilent Technologies, Inc.
CIK 1599882
Stockholm, V7
Position in A
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$2,849,500
+$128,100 QoQ
Shares Held
25,000
+25.0% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in A Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Rhenman & Partners Asset Management AB holds $73,822,363 across 8 Diagnostics & Research names. A ranks #8 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
41,340 | $20,319,850 | |
| 2 | GH |
Guardant Health, Inc.
|
145,000 | $13,393,650 | |
| 3 | NTRA |
Natera, Inc.
|
51,600 | $10,319,484 | |
| 4 | ADPT |
Adaptive Biotechnologies Corp
|
720,000 | $9,993,600 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
53,000 | $9,038,620 | |
| 6 | CRL |
Charles River Laboratories International, Inc.
|
26,000 | $4,485,000 | |
| 7 | DHR |
Danaher Corp /De/
|
18,052 | $3,422,659 | |
| 8 | A |
Agilent Technologies, Inc.
This page
|
25,000 | $2,849,500 |
All Filings in A
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,849,500 | 25,000 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $2,721,400 | 20,000 | Shares | Sole | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||